Acasti Pharma Inc EV/Sales
Was ist das EV/Sales von Acasti Pharma Inc?
EV/Sales von Acasti Pharma Inc ist N/A
Was ist die Definition von EV/Sales?
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
EV/Sales von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Acasti Pharma Inc
Was macht Acasti Pharma Inc?
acasti pharma, inc., a subsiduary of neptune technologies & bioressources, is a quebec-based biopharmaceutical dedicated in advancing a proprietary portfolio based on marine phospholipids. our products can be used in prescription, medical food and over-the-counter applications, either as a stand-alone, or, as a fixed-dose combination to exisitng productrs, for the prevention and treatment of cardiometabolic disorders.
Unternehmen mit ev/sales ähnlich Acasti Pharma Inc
- Leap Therapeutics Inc hat EV/Sales von N/A
- Strike hat EV/Sales von N/A
- VYNE Therapeutics hat EV/Sales von N/A
- Tissue Repair Ltd hat EV/Sales von N/A
- Catheter Precision hat EV/Sales von N/A
- Mirasol Resources hat EV/Sales von N/A
- Acasti Pharma Inc hat EV/Sales von N/A
- Pembroke Venture Capital Trust hat EV/Sales von N/A
- Maven Income & Growth VCT hat EV/Sales von N/A
- Ayala Pharmaceuticals hat EV/Sales von N/A
- Yatra Capital hat EV/Sales von N/A
- SREI Infrastructure Finance hat EV/Sales von N/A
- Aquarius AI hat EV/Sales von N/A